Cargando…

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice

BACKGROUND: This study aimed to determine the incidence of pelvic fistulas in cervical cancer patients treated with bevacizumab in Japanese clinical practice. METHODS: A post-marketing surveillance (PMS) study was conducted between June 2016 and February 2018 to survey physicians who treated advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiyama, Toru, Katsumata, Noriyuki, Toita, Takafumi, Ura, Masako, Shimizu, Ayaka, Kamijima, Shuichi, Aoki, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393147/ https://www.ncbi.nlm.nih.gov/pubmed/35760943 http://dx.doi.org/10.1007/s10147-022-02196-8

Ejemplares similares

Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
por: Motoo, Nagane, et al.
Publicado: (2019)

A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer
por: Sugiyama, Toru, et al.
Publicado: (2017)

Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer
por: Kotaka, Saki, et al.
Publicado: (2023)

External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer
por: Ariga, Takuro, et al.
Publicado: (2013)

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
por: Ueda, Akihiko, et al.
Publicado: (2022)

Predictive factors of uterine movement during definitive radiotherapy for cervical cancer
por: Maemoto, Hitoshi, et al.
Publicado: (2017)

Tracheomediastinal Fistula: Rare Complication of Treatment with Bevacizumab
por: Thawani, Rajat, et al.
Publicado: (2018)

Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports
por: Shoji, Tadahiro, et al.
Publicado: (2018)

Global challenges of radiotherapy for the treatment of locally advanced cervical cancer
por: Mayadev, Jyoti S, et al.
Publicado: (2022)

Predictive factors of posttreatment fracture by definitive radiotherapy for uterine cervical cancer
por: Ishikawa, Kazuki, et al.
Publicado: (2020)

Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose‐volume analysis
por: Tomizawa, Kento, et al.
Publicado: (2021)

Five cases of skin desquamation due to bevacizumab combined with docetaxel-carboplatin in ovarian cancer
por: Tokunaga, Megumi, et al.
Publicado: (2022)

Postoperative bronchopleural fistula after induction therapy with bevacizumab
por: Wada, Hironobu, et al.
Publicado: (2023)

Improvement in radiation techniques for locally advanced cervical cancer during the last two decades
por: Sagae, Satoru, et al.
Publicado: (2023)

A questionnaire-based survey on 3D image-guided brachytherapy for cervical cancer in Japan: advances and obstacles
por: Ohno, Tatsuya, et al.
Publicado: (2015)

Small dose of oral gastrografin for computed tomography-based image-guided brachytherapy in patients with uterine cervical cancer
por: Maemoto, Hitoshi, et al.
Publicado: (2021)

Computed tomography–based image-guided brachytherapy for cervical cancer: correlations between dose–volume parameters and clinical outcomes
por: Kusada, Takeaki, et al.
Publicado: (2018)

Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients
por: Kusada, Takeaki, et al.
Publicado: (2020)

Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients
por: Kusada, Takeaki, et al.
Publicado: (2023)

National survey of intracavitary brachytherapy for intact uterine cervical cancer in Japan
por: Toita, Takafumi, et al.
Publicado: (2018)

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review
por: Karasawa, Yuki, et al.
Publicado: (2022)

Development of fistula between esophagogastric anastomotic site and cartilage portion of trachea after subtotal esophagectomy for cervical esophageal cancer: a case report
por: Taniguchi, Daisuke, et al.
Publicado: (2016)

Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group
por: Katsumata, Noriyuki, et al.
Publicado: (2008)

Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy
por: Sturdza, Alina, et al.
Publicado: (2017)

Surgical treatment for secondary aortoesophageal fistula
por: Sugiyama, Kayo, et al.
Publicado: (2020)

Duodenocaval fistula after bevacizumab therapy: case presentation and complete overview of the literature
por: Giordano, Alessio, et al.
Publicado: (2023)

Profile of bevacizumab and its potential in the treatment of cervical cancer
por: Fisher, Christine M, et al.
Publicado: (2015)

Can Hip-Knee Line Angle Distinguish the Size of Pelvic Incidence?—Development of Quick Noninvasive Assessment Tool for Pelvic Incidence Classification
por: Yamada, Shota, et al.
Publicado: (2022)

A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan
por: Murakami, Naoya, et al.
Publicado: (2015)

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

A case report of vesicovaginal fistula following Bevacizumab without pelvic disease and radiochemotherapy
por: Zhang, Junlong, et al.
Publicado: (2022)

The association between socioeconomic status and reactions to radiation exposure: a cross-sectional study after the Fukushima Daiichi nuclear power station accident
por: Kusama, Taro, et al.
Publicado: (2018)

Bevacizumab for non‐small‐cell lung cancer: A nested case control study of risk factors for hemoptysis
por: Goto, Koichi, et al.
Publicado: (2016)

Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer
por: Kasuya, Goro, et al.
Publicado: (2013)

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients
por: Nishina, Tomohiro, et al.
Publicado: (2013)

Changes in Protein Level in the Cerebrospinal Fluid of a Patient with Cerebral Radiation Necrosis Treated with Bevacizumab
por: Yano, Hirohito, et al.
Publicado: (2014)

Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients
por: Patil, Pratik P., et al.
Publicado: (2021)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Tracheoesophageal Fistula with Bilateral Facial Cleft: A Rare Occurrence
por: Peters, Nitin James, et al.
Publicado: (2023)

Early treatment of progressive vertebral arteriovenous fistula caused by cervical penetrating injury
por: Murakami, Mamoru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hq5nouak09nn2sfa5eki8dhokk